BIO Protocol

BIO Protocol is a decentralized science (DeSci) financial layer that connects global capital and talent with early-stage biotech research. It does this through a network of specialized bioDAOs — community-governed research organizations — backed by the BIO token, which coordinates funding, liquidity, governance, and milestone rewards across the ecosystem. The protocol launched its token generation event on January 3, 2025, and has since expanded to include a project launchpad, an AI agent platform for scientific research, and an onchain liquidity engine pairing BIO with project-specific research tokens.

Core Mechanism

BIO Protocol describes its mission as creating a new category called "Science Finance" (SciFi) — a convergence of decentralized finance and decentralized science. The protocol identifies funding and liquidity as the two primary bottlenecks to scientific progress, and addresses both through five interlocking mechanisms:

Curation — BIO token holders with staked positions (veBIO) vote to admit new biotech projects into the network. This filters for credibility before any capital changes hands.

Ignition Sales — Accepted projects raise early funding through low-cap community sales open to qualifying BIO stakers. These sales are community-priced and structured to scale with research milestones, giving both projects and participants alignment from the start.

Liquidity Engine — Rather than leaving each project to manage its own secondary market, BIO Protocol pairs project tokens with BIO in liquidity pools (for example, VITA/BIO, HAIR/BIO). The protocol earns a 30% cut of trading fees from each pair, feeding a sustainable treasury without requiring ongoing token inflation.

Milestone Rewards (bio/acc) — Projects unlock BIO token rewards by achieving verifiable research milestones: completed lab experiments, clinical trial results, or IP licensing revenue. This creates accountability loops between capital allocation and scientific output.

Meta-Governance — BIO stakers gain voting rights not just at the protocol level but across the bioDAOs in the network, influencing IP strategy, treasury allocation, and operational decisions within each research community.

Taken together, these mechanisms create a flywheel: staking BIO generates governance power and launch access, successful projects increase treasury value and trading volume, and higher trading volume drives more protocol fees and BIO demand.

Key Features

BioDAOs are the primary organizational units. Each bioDAO specializes in a scientific domain and maintains its own governance token alongside its relationship with BIO. Current bioDAOs include VitaDAO (longevity research, VITA), AthenaDAO (women's health), PsyDAO (psychedelic medicine), ValleyDAO (synthetic biology, GROW), HairDAO (HAIR), CryoDAO (CRYO), Cerebrum DAO, Curetopia, Long COVID Labs, and Quantum Biology DAO. The team reports incubating several of these DAOs over three years before launching BIO Protocol as the coordination layer.

BioAgents are autonomous AI entities built to execute specific research and development tasks — from literature review and hypothesis generation to chemical synthesis planning and clinical data interpretation. Each BioAgent can be launched as an independent project within the protocol with its own token and revenue model.

BioXP is a loyalty points system earned through BIO and ecosystem staking. Accumulated BioXP grants priority access to Ignition Sales, incentivizing long-term holders without direct dilution.

OpenLabs, launched in mid-2026, is a collaborative science layer where humans and AI agents can post, discuss, and develop hypotheses in public before they escalate to formal funding proposals.

Tokens and Assets

The BIO token has a fixed total supply of 3.32 billion tokens. Initial allocation: 56% to the community (20% auction, 6% airdrop, 25% ecosystem incentives, 5% to Molecule), 21.2% to core contributors, 13.6% to early backers, and 4.2% to advisors. Vesting is long-tailed: core contributors and advisors carry a one-year cliff then six-year linear vest; investors have a one-year cliff with a four-year vest.

BIO stakers receive veBIO granting governance rights over protocol upgrades and treasury meta-governance. The token launched simultaneously on Ethereum and Solana at TGE (January 3, 2025) and subsequently expanded to Base and BNB Chain. Solana contract: bioJ9JTqW62MLz7UKHU69gtKhPpGi1BQhccj2kmSvUJ.

Audits and Security

No specific third-party audit disclosures were surfaced during research. The protocol is governed by Bio.xyz Association, a not-for-profit legal steward. The multi-sig treasury structure uses 5-of-9 signing for main treasury and 3-of-5 for operations. Prospective participants should verify audit status directly at docs.bio.xyz.

Team and Background

BIO Protocol grew from the Molecule ecosystem — Molecule pioneered IP-NFTs, the primitive that represents scientific intellectual property as onchain assets. The core team incubated VitaDAO, ValleyDAO, and CryoDAO over three years before launching BIO Protocol as their coordination layer. Binance Labs made their first-ever DeSci investment in Bio Protocol during November 2024, and the BIO Genesis fundraise exceeded $33 million. Individual founder names were not disclosed in official materials.

Solana Fit

BIO Protocol launched its token natively on Solana at TGE, making it one of the few DeSci protocols with genuine multichain presence from day one. Solana's low transaction costs suit the BIO liquidity engine, where frequent small trades between research tokens and BIO need to remain economical. The protocol's multichain approach — Ethereum for institutional governance depth, Solana for trading efficiency, Base and BNB for reach — reflects a deliberate strategy of sourcing liquidity wherever it naturally concentrates.